A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

Conditions: Non-small Cell Lung Cancer (NSCLC); Cachexia

Interventions: Drug: ponsegromab; Drug: placebo

Sponsors: Pfizer

Not yet recruiting